HHS) has proposed a relaxation of the regulations surrounding marijuana, according to a report from Bloomberg News on Wednesday. The report cites a letter written to the Drug Enforcement Agency (DEA) administrator, Anne Milgram. The letter, authored by Rachel Levine, the US Assistant Secretary for Health, specifically requests the reclassification of marijuana from its current category to a Schedule III drug as defined by the Controlled Substances Act.
Marijuana is currently classified as a Schedule I drug. About 40 US states have legalized marijuana use in some form, but it remains completely illegal in some states and at the federal level.
The DEA confirmed it had received a letter from the HHS providing its findings and recommendation on marijuana scheduling, pursuant to US President Joe Biden's request for a review.
«The administration's process is an independent process led by HHS, led by the Department of Justice and guided by evidence… we will let that process move forward,» White House Press Secretary Karine Jean-Pierre said.
The HHS did not immediately respond to a Reuters' request for a comment.
«As part of this process, HHS conducted a scientific and medical evaluation for consideration by DEA. DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act. DEA will now initiate its review,» according to a DEA spokesperson.
Cannabis firms such as Verano Holdings and Sunburn Cannabis welcomed the HHS move.
«For far too long, cannabis prohibition and its outdated status as a schedule I substance have unduly harmed countless individuals affected by the failed War on Drugs,» Veranos CEO George Archos said.
Q1. What is the status of Marijuana in US?
A